106 / 119
105
Diretrizes AMB
Efficacy and safety results from the randomized controlled comparative
study of adalimumab vs. methotrexate vs. placebo in patients with
psoriasis (CHAMPION). Br J Dermatol. 2008 Mar;158(3):558-66. Epub
2007 Nov 28. PubMed PMID: 18047523.
20. Revicki D, Willian MK, Saurat JH, Papp KA, Ortonne JP, Sexton C,
Camez A. Impact of adalimumab treatment on health-related quality of
life and other patient-reported outcomes: results from a 16-week
randomized controlled trial in patients with moderate to severe plaque